Translate Discoveries
Baylor Genetics
Baylor Miraca Genetics Laboratories, a joint venture of Baylor College or Medicine and Miraca Holdings, Inc., rebranded as Baylor Genetics.
Exclusive License to ViraCyte, Inc.
Developing cytotoxic T-lymphocyte (CTL) products for the treatment of virus infectious/activation events after hematopoietic stem cell transplant.
Consultagene Virtual Platform for Genetics Services
Consultagene, a product of Baylor College of Medicine faculty and partners from Baylor Genetics, is a personalized web and app-based platform that integrates research and clinical care through genetic counseling, peer-to-peer consultation, patient and provider education and diagnostic interpretation of clinical genomic data.
Scalp Cooling Effective in Reducing Hair Loss During Chemotherapy
An oncologist at the Lester and Sue Smith Breast Center within the NCI-designated Dan L Duncan Comprehensive Cancer Center achieved results in research studying the effectiveness of scalp cooling therapy in reducing hair loss in women undergoing some chemotherapy regimens.
Cell Medica
Baylor College of Medicine and Cell Medica announce groundbreaking collaboration to create cellular immunotherapy products for cancer treatment.
Baylor Road Map
Our seven-year strategic road map provides the blueprint for leveraging Baylor's collaborative environments and historic leadership in research to form a new paradigm for integrated health sciences universities.
Annual Report
Read the full 2017 Baylor College of Medicine Annual Report.